ETF Holdings Breakdown of FLGT

Stock Name	Fulgent Genetics Inc
Ticker	FLGT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US3596641098
LEI	549300CL6P01M68QJ404

FLGT institutional holdings

The following institutional investment holdings of FLGT have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-29 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 14,604 USD 325,669

2025-09-29 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 40,265 USD 897,910

2025-09-29 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,999 USD 44,578 -1.3%

Total = 56,868 USD 1,268,157
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-29	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	14,604	USD 325,669
2025-09-29	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	40,265	USD 897,910
2025-09-29	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,999	USD 44,578 -1.3%
Total =	56,868	USD 1,268,157

News associated with FLGT

Federated Hermes Inc. Boosts Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT): Federated Hermes Inc. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 11.0% during the 1st quarter, HoldingsChannel reports. The fund owned 46,479 shares of the company’s stock after acquiring an additional 4,597 shares during the period. Federated Hermes Inc.’s holdings in Fulgent Genetics were worth $785,000 at the end […] - 2025-08-08 05:10:53
Fulgent Genetics (NASDAQ:FLGT) Upgraded to “Buy” at UBS Group: UBS Group upgraded shares of Fulgent Genetics (NASDAQ:FLGT – Free Report) from a neutral rating to a buy rating in a report published on Tuesday, Marketbeat reports. The firm currently has $30.00 price objective on the stock, up from their prior price objective of $20.00. A number of other brokerages also recently issued reports on […] - 2025-08-06 04:38:58
Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price: Fulgent Genetics (NASDAQ:FLGT – Get Free Report) had its target price lowered by analysts at Piper Sandler from $23.00 to $21.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 1.06% from […] - 2025-08-06 02:52:55
Fulgent Genetics (NASDAQ:FLGT) Shares Down 3.4% After Analyst Downgrade: Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Free Report)’s share price dropped 3.4% on Monday after Piper Sandler lowered their price target on the stock from $23.00 to $21.00. Piper Sandler currently has a neutral rating on the stock. Fulgent Genetics traded as low as $17.92 and last traded at $17.90. Approximately 59,010 shares were traded […] - 2025-08-06 02:13:03
Fulgent Genetics (NASDAQ:FLGT) & Outset Medical (NASDAQ:OM) Head-To-Head Analysis: Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Outset Medical (NASDAQ:OM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations and institutional ownership. Institutional and Insider Ownership 48.1% of Fulgent […] - 2025-07-23 04:07:07
Alps Advisors Inc. Sells 1,980 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT): Alps Advisors Inc. lessened its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 8.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,752 shares of the company’s stock after selling 1,980 shares during the period. Alps […] - 2025-07-16 05:23:11
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,654 shares of the company’s stock after […] - 2025-06-11 04:36:52
Two Sigma Investments LP Reduces Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT): Two Sigma Investments LP cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 80,082 shares of the company’s stock after selling 2,749 shares during the period. Two Sigma Investments LP’s […] - 2025-06-04 05:08:51
Squarepoint Ops LLC Grows Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT): Squarepoint Ops LLC boosted its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 178.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,608 shares of the company’s stock after buying an additional 26,659 shares during the quarter. Squarepoint Ops LLC owned […] - 2025-06-03 05:04:50
State of Wyoming Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT): State of Wyoming bought a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,109 shares of the company’s stock, valued at approximately $57,000. Several other hedge funds and other institutional investors […] - 2025-05-29 04:47:02
Quantinno Capital Management LP Makes New Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT): Quantinno Capital Management LP acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 13,079 shares of the company’s stock, valued at approximately $242,000. Several other large investors have also recently added to or reduced their stakes in the company. Millennium […] - 2025-05-27 04:56:53
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $987,000 Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 53,413 shares of the company’s stock after selling 2,800 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Fulgent Genetics were […] - 2025-05-26 04:43:01
Deutsche Bank AG Has $2.43 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT): Deutsche Bank AG raised its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 6.1% during the fourth quarter, Holdings Channel reports. The firm owned 131,430 shares of the company’s stock after purchasing an additional 7,532 shares during the period. Deutsche Bank AG’s holdings in Fulgent Genetics were worth $2,428,000 at the end of […] - 2025-05-22 05:36:54
Balyasny Asset Management L.P. Buys Shares of 26,313 Fulgent Genetics, Inc. (NASDAQ:FLGT): Balyasny Asset Management L.P. bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 26,313 shares of the company’s stock, valued at approximately $486,000. Balyasny Asset Management L.P. owned 0.09% of […] - 2025-05-16 05:50:59
Comparing Fulgent Genetics (NASDAQ:FLGT) and Grail (NASDAQ:GRAL): Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Grail (NASDAQ:GRAL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Institutional & Insider Ownership 48.1% of Fulgent Genetics […] - 2025-05-12 02:54:58
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Dimensional Fund Advisors LP: Dimensional Fund Advisors LP reduced its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,045,815 shares of the company’s stock after selling 60,579 shares during the period. Dimensional Fund Advisors LP’s holdings in Fulgent Genetics were worth $19,316,000 as of its most recent […] - 2025-05-08 04:50:45
Barclays PLC Raises Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT): Barclays PLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 180,397 shares of the company’s stock after acquiring an additional 5,542 shares during the quarter. Barclays PLC’s holdings in Fulgent Genetics were worth $3,332,000 as of its most […] - 2025-04-29 05:18:59
Federated Hermes Inc. Buys 1,774 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT): Federated Hermes Inc. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 4.4% in the fourth quarter, HoldingsChannel reports. The fund owned 41,882 shares of the company’s stock after acquiring an additional 1,774 shares during the period. Federated Hermes Inc.’s holdings in Fulgent Genetics were worth $774,000 as of its […] - 2025-04-16 05:13:02
Piper Sandler Has Lowered Expectations for Fulgent Genetics (NASDAQ:FLGT) Stock Price: Fulgent Genetics (NASDAQ:FLGT – Get Free Report) had its price target cut by equities researchers at Piper Sandler from $22.00 to $16.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price objective suggests a potential downside of 3.90% from the stock’s current price. Separately, […] - 2025-03-06 05:27:14
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund cut its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 12.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,609 shares of the company’s stock after selling 1,324 shares during the quarter. Illinois Municipal Retirement […] - 2025-03-05 08:01:50
SG Americas Securities LLC Cuts Position in Fulgent Genetics, Inc. (NASDAQ:FLGT): SG Americas Securities LLC cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 28.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 12,518 shares of the company’s stock after selling 4,934 shares during the quarter. SG Americas Securities LLC’s holdings in Fulgent Genetics were worth $231,000 as of its most […] - 2025-02-07 06:25:42
Exchange Traded Concepts LLC Has $652,000 Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT): Exchange Traded Concepts LLC increased its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,324 shares of the company’s stock after acquiring an additional 1,689 shares […] - 2025-01-30 06:53:06

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.